Financial Performance - The company's operating revenue for Q1 2019 was ¥67,767,425.29, representing a decrease of 21.23% compared to ¥86,036,603.08 in the same period last year[7] - The net profit attributable to shareholders was a loss of ¥12,792,592.57, a decline of 458.80% from a profit of ¥3,565,354.61 in the previous year[7] - Basic and diluted earnings per share were both -¥0.0124, a decrease of 454.29% from ¥0.0035 in the same period last year[7] - The company reported a net loss of CNY 466,750,198.51, slightly improved from a loss of CNY 465,552,705.22 in the previous period[34] - The net profit for the current period was CNY -13,869,371.55, while the previous period showed a net profit of CNY 5,165,146.31, reflecting a substantial loss[38] Cash Flow - The net cash flow from operating activities was negative at ¥13,726,806.75, down 341.89% from ¥5,674,906.54 in the prior year[7] - Cash flow from operating activities was CNY 88,874,047.29, down from CNY 99,899,281.07 in the previous period, indicating a decline in cash inflow[44] - Total cash inflow from operating activities was 89,048,060.82 yuan, while cash outflow was 102,774,867.57 yuan, resulting in a net outflow of 13,726,806.75 yuan[45] - Cash flow from investment activities showed a net outflow of -1,287,510.00 yuan, compared to -3,794,662.13 yuan in the previous period[46] - Cash flow from financing activities resulted in a net outflow of -1,278,750.01 yuan, a significant decrease from -15,480,999.99 yuan in the previous period[46] Assets and Liabilities - Total assets at the end of the reporting period were ¥895,384,004.54, down 3.29% from ¥925,876,050.58 at the end of the previous year[7] - The company reported total liabilities amounted to CNY 129,628,960.26, a slight decrease from CNY 130,304,404.35 in the previous period[33] - The company's equity attributable to shareholders decreased to CNY 601,539,982.85 from CNY 602,737,476.14[34] - Cash and cash equivalents decreased by 40.77% to ¥23,352,246.17 from ¥39,429,625.90 due to concentrated payments for maintenance fees and land rent[15] Shareholder Information - The total number of common shareholders at the end of the reporting period was 82,895[10] - The largest shareholder, Wang Hongming, holds 14.00% of the shares, amounting to 144,138,394 shares[10] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[11] Research and Development - Research and development expenses increased significantly by 325.40% to ¥8,681,804.90 from ¥2,040,838.16, reflecting increased R&D spending in Beijing[15] - The company reported no revenue from new product launches or technological advancements during the current period[41] Other Income and Expenses - The company reported non-recurring gains and losses totaling ¥113,428.22 for the period[8] - Other income was recorded at ¥116,579.55, a significant increase of 2141.91% compared to ¥5,200.00, due to penalty income from a contract breach[15] - The company incurred management expenses of CNY 879,329.72 in the current period, a decrease from CNY 4,162,896.00 in the previous period[40] Investigations and Compliance - There are ongoing investigations by the China Securities Regulatory Commission regarding potential violations of information disclosure laws[17] - The company has not engaged in any securities or derivative investments during the reporting period[18][19]
四环生物(000518) - 2019 Q1 - 季度财报